Title: Chih-long Chang: Innovator in Immunogenic Glycopeptides
Introduction
Chih-long Chang is an inventor based in Taipei, Taiwan. He has made significant contributions to the field of immunogenic glycopeptides. Although he currently holds no granted patents, his work is focused on developing innovative solutions for cancer treatment.
Latest Patent Applications
Chih-long Chang's latest patent applications include:
1. **Antibodies Against Immunogenic Glycopeptides, Compositions Comprising the Same and Use Thereof** - This application discloses antibodies that specifically bind to at least one epitope defined by the immunogenic glycopeptide. It also covers pharmaceutical compositions comprising the antibody and methods for preventing and/or treating Globo-H-positive cancer.
2. **Immunogenic Glycopeptide Compounds, Pharmaceutical Compositions and Uses Thereof** - This application reveals immunogenic glycopeptide compounds designed to induce immune responses for the prevention and/or treatment of cancer. It further discusses pharmaceutical compositions comprising these compounds and methods for their use in treating cancer in subjects.
Conclusion
Chih-long Chang is an innovative inventor whose work in immunogenic glycopeptides holds promise for advancing cancer treatment. His latest patent applications reflect his commitment to developing effective therapeutic solutions.